Timothy Rolph, the Chief Scientific Officer of $AKRO ($AKRO), sold 2,450 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4%...
Patrick Lamy, the Senior VP of $AKRO ($AKRO), sold 925 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.9% of their shares....
Over 40% of EFX 50mg participants experienced liver fibrosis regression after 96 weeks, demonstrating significant clinical efficacy.Quiver AI SummaryAkero Therapeutics announced promising results from...
Sagimet Biosciences’ SGMT stock rose 12.6% on Tuesday after it announced that the FDA has granted breakthrough therapy designation (“BTD”) to its lead pipeline candidate, denifanstat, for treating...
Stocks that traded heavily or had substantial price changes on Monday: Macy’s, United Rentals rise; Apple, Spirit Airlines fall